EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Guanosine Attenuates Astrocyte-Associated Glutamatergic Dysregulation and Improves Survival in Acute Liver Failure-Induced Hepatic Encephalopathy

Pedro Arend Guazzelli, Felipe Dos Santos Fachim, Anderson Santos Travassos, Yasmine Nonose, Andréia Silva da Rocha, Francieli Rohden iD, Fernanda Urruth Fontella, Adriano Martimbianco de Assis iD, Diogo Onofre Souza

Metabolites · 18.08.2026 · 16 (8) · 587

DOI: 10.3390/metabo16080587 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Metabolites, online erschienen am 18.08.2026. Verfasst von Pedro Arend Guazzelli und 8 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Biological Sciences: Biochemistry, Instituto de Ciências Básicas da Saúde (ICBS), Universidade Federal do Rio Grande do Sul-UFRGS…. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Brazilian Federal Agency for Support and Evaluation of Graduate Education, Institutos Nacionais de Ciência e Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Acute liver failure (ALF) rapidly induces hepatic encephalopathy (HE), a severe neurological syndrome associated with astrocytic dysfunction and glutamatergic dysregulation. Guanosine (GUO), an endogenous guanine-based nucleoside, has neuroprotective properties, but its effects on astrocyte-associated glutamate regulation in ALF-induced HE remain incompletely understood. This study tested whether GUO attenuates neurological deterioration and glutamatergic dysfunction in an experimental model of ALF-induced HE.

Methods

Male Wistar rats underwent 92% subtotal hepatectomy and received intraperitoneal GUO (7.5 mg/kg) or saline at prespecified time points after surgery. Neurological severity and survival were monitored for 72 h. Astrocytic morphology was assessed by GFAP immunofluorescence. Cerebrospinal fluid (CSF) albumin, glutamate, and glutamine levels, cortical Na+-dependent glutamate uptake, GLAST immunocontent, and the 67 kDa GLT-1 monomer immunocontent were evaluated.

Results

Subtotal hepatectomy induced progressive neurological impairment, high mortality, GFAP-associated astrocytic remodeling, increased CSF albumin, glutamate, and glutamine levels, and reduced cortical glutamate uptake. GUO attenuated neurological deterioration and increased 72 h survival from 10.5% to 39.0% (log-rank p = 0.03). GUO also reduced CSF albumin, glutamate, and glutamine concentrations and improved cortical Na+-dependent glutamate uptake without altering GLAST or GLT-1 monomer immunocontent.

Conclusions

GUO attenuated astrocyte-associated glutamatergic dysregulation and improved survival in ALF-induced HE. These findings support further mechanistic and translational investigation of GUO as an experimental modulator of astrocyte-associated glutamate handling in ALF-induced HE.

Schlagwörter

Stichwörter der Autor:innen

acute liver failureastrocytescerebrospinal fluid biomarkersglutamate uptakeguanosinehepatic encephalopathyneuroprotection

Autor:innen und Institutionen

  • Graduate Program in Biological Sciences: Biochemistry, Instituto de Ciências Básicas da Saúde (ICBS), Universidade Federal do Rio Grande do Sul-UFRGS, Porto Alegre 90035-003, RS, Brazil.
  • Graduate Program in Health and Behaviour, Center of Health Science, Universidade Católica de Pelotas-UCPel, Pelotas 96015-560, RS, Brazil.
  • Department of Biochemistry, Universidade Federal do Rio Grande do Sul-UFRGS, Porto Alegre 90035-003, RS, Brazil.

ORCID-Profile: Francieli Rohden, Adriano Martimbianco de Assis

Förderung

  • National Council for Scientific and Technological Development
  • Brazilian Federal Agency for Support and Evaluation of Graduate Education
  • Institutos Nacionais de Ciência e Tecnologia
  • the National Council for Scientific and Technological Development—CNPq
  • Coordination for the Improvement of Higher Education Personnel—CAPES
  • INCT/Excitotoxicity and Neuroprotection

Zitieren

APA

Guazzelli, P. A., Fachim, F. D. S., Travassos, A. S., Nonose, Y., da Rocha, A. S., Rohden, F., Fontella, F. U., de Assis, A. M., & Souza, D. O. (2026). Guanosine Attenuates Astrocyte-Associated Glutamatergic Dysregulation and Improves Survival in Acute Liver Failure-Induced Hepatic Encephalopathy. Metabolites, 16(8), 587. https://doi.org/10.3390/metabo16080587

Vancouver

Guazzelli PA, Fachim FDS, Travassos AS, Nonose Y, da Rocha AS, Rohden F, et al. Guanosine Attenuates Astrocyte-Associated Glutamatergic Dysregulation and Improves Survival in Acute Liver Failure-Induced Hepatic Encephalopathy. Metabolites. 2026;16(8):587. doi:10.3390/metabo16080587

BibTeX
@article{Guazzelli2026,
  author = {Guazzelli, Pedro Arend and Fachim, Felipe Dos Santos and Travassos, Anderson Santos and Nonose, Yasmine and da Rocha, Andréia Silva and Rohden, Francieli and Fontella, Fernanda Urruth and de Assis, Adriano Martimbianco and Souza, Diogo Onofre},
  title = {Guanosine Attenuates Astrocyte-Associated Glutamatergic Dysregulation and Improves Survival in Acute Liver Failure-Induced Hepatic Encephalopathy},
  journal = {Metabolites},
  year = {2026},
  volume = {16},
  number = {8},
  pages = {587},
  doi = {10.3390/metabo16080587}
}
Kostenlos starten →